Experimental Hematology
Volume 34, Issue 8 , Pages 1033-1040, August 2006

Migration and function of FoxP3+ regulatory T cells in the hematolymphoid system

  • Chang H. Kim

      Affiliations

    • Corresponding Author InformationOffprint requests to: Chang H. Kim, Department of Pathobiology (VPTH 126), 725 Harrison Street, Purdue University, West Lafayette, IN

Laboratory of Immunology and Hematopoiesis, Department of Pathobiology, Purdue Cancer Center, Purdue University, West Lafayette, Ind., USA

FoxP3+ T cells play critical roles in regulation of the hematolymphoid system and prevention of autoimmunity. Many FoxP3+ T cells, generated in thymus as the result of T cell receptor (TCR) recognition of self antigens, preferentially migrate to secondary lymphoid tissues such as lymph nodes and spleen in a manner similar to conventional naïve T cells. FoxP3+ T cells differentiated in the periphery acquire homing phenotype to bone marrow and nonlymphoid tissues. Consistently, lymphoid- and nonlymphoid-tissue-homing FoxP3+ T cell subsets express different trafficking and chemokine receptors. FoxP3+ T cells regulate hematopoiesis by limiting the activation of immune cells and their production of hematopoietic cytokines available for stem and progenitor cells. In mice deficient in FoxP3+ T cells, aberrant regulation of hematopoiesis including excessive myelopoiesis occurs. In transplantation of allogenic hematopoietic cells, FoxP3+ T cells selectively suppress harmful graft-vs-host disease (GVHD) but leave beneficial graft-vs-leukemia (GVL) activity intact. Therefore, FoxP3+ T cells play essential roles in regulation of the hematolymphoid system in health and diseases, and are likely to be utilized as effective therapeutics for many diseases in the hematolymphoid system in the future.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(06)00235-9

doi:10.1016/j.exphem.2006.03.014

Experimental Hematology
Volume 34, Issue 8 , Pages 1033-1040, August 2006